doi:10.3969/j.issn.1006-0111.2017.05.024

Message Board

Respected readers, authors and reviewers, you can add comments to this page on any questions about the contribution, review, editing and publication of this journal. We will give you an answer as soon as possible. Thank you for your support!

Name
E-mail
Phone
Title
Content
Verification Code

x Close Forever Close

PDF
Cite
Share

facebook

twitter

google

linkedin

Volume 35 Issue 5

Turn off MathJax

Article Contents

Article Navigation > Journal of Pharmaceutical Practice and Service > 2017 > 35(5): 479-480

doi: 10.3969/j.issn.1006-0111.2017.05.024

Received Date: 2016-12-15
Rev Recd Date: 2017-03-25

References

[1]	谭曼红,姜春燕,罗佳. 雷贝拉唑致免疫介导性药物性肝损伤1例［J］. 肝脏,2014,16(2):175-176.
[2]	中华医学会肝病学分会药物性肝病学组. 药物性肝损伤诊治指南［J］. 中华肝脏病杂志,2015,23(11):810-820.
[3]	Johnstone D, Berger C, Fleckman P, et al. Acute fulminant hepatitis after treatment with rabeprazole and terbinafine［J］. Arch Intern Med, 2001,161:1677-1678.
[4]	Zaccardi F, Pitocco D, Martini L, et al. A case of esomeprazole-induced transient diabetes and hepatitis: the role of liver inflammation in the pathogenesis of insulin resistance ［J］. Acta Diabetol, 2014, 51: 151-153.
[5]	董东方,王群英,钟慧闽. 埃索美拉唑镁致肝功能异常1例［J］. 山东医药, 2008, 48(4): 21.
[6]	Gomez MR, Otero MA, Fobelo MJ, et al. Acute hepatitis related to omeprazole ［J］. Am J Gastroenterol, 1999, 94(4): 1119-1120.